Management of vitiligo;TRATAMIENTO DEL VITILIGO

Actas Dermo-Sifiliograficas

Volumn 87, Issue 5, 1996, Pages 217-232

  Jimenez Reyes, Jose ^a   Barrios, Ma Isabel ^a   Gonzalez Herrada, Carlos ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

Author keywords

5 f luorouracil; clofazimine; cutaneous grafts; khellin; phenylalanine; psoralens; PUVA; steroids; vitiligo

Indexed keywords

BERGAPTEN; BETAMETHASONE; CLOBETASOL; CLOFAZIMINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUOROURACIL; IMMUNOMODULATING AGENT; KHELLIN; LEVAMISOLE; METHOXSALEN; PHENYLALANINE; PREDNISOLONE; PREDNISONE; PSORALEN; TRIAMCINOLONE ACETONIDE; TRIMETHYLPSORALEN;

DRUG ACTIVITY; DRUG EFFICACY; HUMAN; ORAL DRUG ADMINISTRATION; PUVA; REVIEW; SKIN GRAFT; TOPICAL DRUG ADMINISTRATION; VITILIGO;

EID: 0030008935     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. a ed. Buenos Aires: Editorial Panamericana, 1988; 947-958.
2. El Mofty A M. A preliminary clinical report on the treatment of leukoderma with Ammi majus. Linn J Egypt Med Assoc 1948; 31: 651-660.
3. Fulton J E Jr, Leyden J, Papa C. Treatment of vitiligo with topical methoxsalen and blacklite. Arch Dermatol 1969; 100: 224-229.
4. Kenney J A. Vitiligo treated by psoralens. A long-term follow-up study of the permanency of repigmentation. Arch Dermatol 1971; 103: 465-480.
5. Lerner A B, Denten C R, Fitzpatrick T B. Clinical experimental studies with 8-methoxypsoralen in vitiligo. J Invest Dermatol 1959; 20: 299-305.
6. Parrish J A, Fitzpatrick T B, Shea C et al. Photochemotherapy of vitiligo. Use of orally administered psoralens and high intensity long-wave ultraviolet light system. Arch Dermatol 1976; 112: 1531-1534.
7. Pathak M A, Mosher D B, Fitzpatrick T B. Safety and therapeutic effectiveness of 8-methoxypsoralen, 4,5,8-trimethylpsoralen, and psoralen in vitiligo. Natural Cancer Institute Monograph. Photochemotherapeutic aspects of psoralens 1984; 66: 165-173.
8. a ed. Buenos Aires: Editorial Panamericana, 1988; 1700-1726.
9. Grimes P E. Vitiligo. En: Dermatologic Clinics. Philadelphia: Saunders Company, 1993; 325-338.
10. Stern R S, Parrish J A, Fitzpatrick T B. Ocular findings in patients treated with PUVA. J Invest Dermatol 1985; 85: 269-273.
11. Stern R S. Genital tumors among men with psoriasis exposed to psoralen and ultraviolet A radiation (PUVA) and ultraviolet B radiation. N Engl J Med 1990; 322: 1093-1097.
12. Stern R S, Lange R. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol 1988; 91: 120-124.
13. El Mofty A M, El Sawalhy H, El Mofty M. Clinical study of a new preparation of 8-methoxypsoralen in photochemotherapy. Int J Dermatol 1994; 33: 588-592.
14. Ortel B, Tanew A, Hönigsmann H. Treatment of vitiligo with khellin and ultraviolet A. J Am Acad Dermatol 1988; 18: 693-701.
15. Galal E, Kandil A, Abdel-Latif M. Acute toxicity of Ammi visnaga principles. J Drug Res Egypt 1975; 7: 1-7.
16. Abdel-Fattah A, Aboul-Enein M N, Wassel G et al. An approach to the treatment of vitiligo by khellin. Dermatologica 1982; 165: 136-140.
17. Jansen T, Megahed M, Holzle E, Plewig C. Provocation of porphyria cutanea tarda by KUVA-therapy of vitiligo. Acta Derm Venereol 1995; 75: 232-233.
18. Morliere P, Honigsmann H, Averbeck D et al. Phototherapeutic photobiologic and photosensitizing properties of khellin. J Invest Dermatol 1988; 90: 720-724.
19. Cormane R H, Siddiqui A H, Westerhof W et al. Phenylalanine and UVA light for the treatment of vitiligo. Arch Dermatol Res 1985; 277: 126-130.
20. Antoniou C, Schulpis H, Michas T et al. Vitiligo theraphy with oral and topical phenylalanine with UVA exposure. Int J Dermatol 1989; 28: 545-547.
21. Thiele B. Photochemotherapy using L-phenylalanine and UV light (PAUVA) as an alternative treatment concept in vitiligo. Aktuel Dermatol 1991; 17: 53-57.
22. Camacho F. L-fenilalanina en el tratamiento del vitiligo. Monogr Dermatol 1995; 8: 190-204.
23. Greiner D, Ochsendorf F R, Milbradt R. Vitiligo therapy with phenylalanine/UVA Catamnestic studies after five years. Hautarzt 1994; 45: 460-463.
24. Ryan W, Carver M. Inhibition of antibody synthesis by L-phenylalanine. Science 1963; 43: 479-480.
25. Westerhof W, Groot I, Krieg S R et al. Langerhans cell population studies with OKT6 and HLA-DR monoclonal antibodies in vitiligo patients treated with oral phenylalanine loading and UVA irradiation. Acta Derm Venereol 1986; 66: 259-274.
26. Gupta A K, Ellis C N, Nickoloff B J et al. Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. Arch Dermatol 1990; 126: 339-350.
27. Gokhale B B. Parakh A P. Cvclophosphamide in vitiligo. Int J Dermatol 1983; 28: 7-10.
28. Galbraith G M P. Therapeutic immunomodulation. En: Dermatologic clinics. Saunders Company Philadelphia, 1988; 561-568.
29. Mohammed A. Vitiligo repigmentation with anapsos (abstract). Int J Dermatol 1989; 28: 479.
30. Mohammed Mustafá A, Calderón R A, Mora I M. Tratamiento oral y tópico del vitiligo con Polypodium leucotomos. Libro de resúmenes del XXIV Congreso Nacional de Dermatología y Venereología. Salamanca, 1995; 254.
31. Jaén P. Empleo del extracto de Polypodium leucotomos en el tratamiento del vitíligo. Monogr Dermatol 1995; 8: 221-228.
32. Stiehm E R. Therapy of immunodeficiency. En: Allergic diseases of Infancy, Childhood and Adolescence. Ed. Bierman C W, Pearlman D S. Philadelphia: W B Saunders Company, 1980; 95-104.
33. Pasricha J S, Khera V. Effect of prolonged treatment with levamisole on vitiligo with limited and slow-spreading disease. Int J Dermatol 199-4; 33: 584-587.
34. Gokhale B B, Gokhale T B. Corticotrophin and vitiligo (preliminary observations). Br J Dermatol 1976; 95 329.
35. Hernández Pérez E. Vitiligo treated with ACTH. Int J Dermatol 1979; 18: 578-579.
36. Inamura S, Tagami H. Treatment of vitiligo with oral corticosteroids. Dermatologica 1976; 153: 179-185.
37. Thomas P S. Prednisolone causing amelioration of both vitiligo and chronic active hepatitis. Br J Hosp Med 1987; 38: 464
38. Brostoff H, Brostoff J, Vitiligo and steroids. Lancet 1978; 2: 688.
39. Goldstein E, Haberman H F, Menon I A et al. Non-psoralen treatment of vitiligo. Part I. Cosmetics, systemic coloring agents and corticosteroids. Int J Dermatol 1992; 31 (4): 229-236.
40. Bor S. Clofazimine in the treatment of vitiligo S Afr Med J 1973; 47: 1451-1454.
41. Punshi S K. Lamprene in vitiligo. Indian J Derm Vener Lepr 1977; 43: 315-316.
42. Shukla S R. Evaluation of clofazimine in vitiligo. Dermatologica 1981; 163 169-171.
43. Srinivas C R. Shenoi S D, Balachandran C. Acceleration of repigmentation in vitiligo by topical minoxidil in patients on photochemotherapy. Int J Dermatol 1990; 20: 154-155.
44. Koshevenko L. Alpha-tocopherol in the combined treatment of vitiligo. Vestm Dermatol Venereol 1989; 10: 70-72.
45. Kandil E. Vitiligo response to 0.2% betamethasone 17-valerate in flexible colodion. Dermatologica 1970; 141: 277-281.
46. Koopmans-Van Dorp B, Goedhart-Van Dijk B, Neering H et al. Treatment of vitiligo by local application of betamethasone 17-valerate in a dimethilsulfoxide cream base. Dermatologica 1973; 146: 1310-1314.
47. Kandil E. Treatment of vitiligo with 0.1% betamethasone 17-valerate in isopropylalcohol. A double-blind trial. Br J Dermatol 1974; 91: 457-460.
48. Bleehen S S. The treatment of vitiligo with topical corticoteroid. Light and electronmicroscopic studies. Br J Dermatol 1976: 94 (suppl 12). 43-50.
49. Clayton R. A double-blind trial of 0.05% clobetasol propionate in the treatment of vitiligo. Br J Dermatol 1977; 96: 71-73.
50. Koga M. Vitiligo: a new classification and therapy. Br J Dermatol 1977; 97: 255-261.
51. Kumari J. Vitiligo treated with topical clobetasol propionate. Arch Dermatol 1984; 120: 631-635.
52. Gnozhu H, Changgeng S, Ganyun Y et al. The therapeutic effect of sicorten ointment in patients with vitiligo. Br J Clin Pract 1985; 434-436.
53. Geráldez C B, Gutiérrez G T. A clinical trial of clobetasol propionate in Filipino vitiligo patients. Clin Ther 1987; 9: 474-482.
54. Kandil E. Treatment of localized vitiligo with intradermal injections of triamcinolone acetonide. Dermatologica 1970; 140: 195-206.
55. Vasistha I K, Singh G. Vitiligo and intralesional steroids. Indian J Med Res 1979; 69: 308-311.
56. Tsuji T, Hamada T. Topically administered fluoruracil in vitiligo. Arch Dermatol 1983; 119: 722-727.
57. Szekeres E, Morbay M. Repigmemation of vitiligo macules treated topically with Efudix cream. Dermatologica 1985; 171: 55-59.
58. Ortonne J P. Psoralen therapy in vitiligo. Clinics in Dermatology 1989; 7: 120-135.
59. Grimes P E, Minus H R, Chakrabarti S G. Determination of optimal topical photochemotherapy for vitiligo. J Am Acad Dermatol 1982; 7: 771-778.
60. Grimes P E, Kelly A P, Cline D J et al. Management of vitiligo in children. Pediatr Dermatol 1986; 3: 498-510.
61. Simini S. Topical khellin phototherapy. Grenoble 1st European Meeting of Photobiology, 1986.
62. Alomar A. Tratamiento topico del vitiligo. Monogr Dermatol 1995; 8: 205-210.
63. Cao C M. Melagenina: un producto cubano. Un fármaco nuevo y eficaz para el tratamiento del vitiligo. Serie de Comunicaciones Nacionales de la República de Cuba. La Habana, 1986.
64. Suite M, Quamina D B E. Treatment of vitiligo with topical melagenine- a human placental extract. J Am Acad Dermatol 1991, 24: 1018-1019
65. Urbanek R W. Tar vitiligo therapy. J Am Acad Dermatol 1983; 8: 755.
66. Schallreuter K U, Wood J M, Lenike K R, Levenig C. Treatment of vitiligo with a topical application of Pseudocatalase and calcium in convination with short-term UVB Exposure: a case study on 33 patients. Dermatology 1995; 190: 223-229.
67. Puig L, Alegre M. Nuevas perspectivas terapéuticas para el vitíligo. Piel 1995; 10: 449-451.
68. Falabella R. Grafting and transplantation of melanocytes for repigmentary vitiligo and other types of leukoderma. Int J Dermatol 1989; 28 363-369.
69. Falabella R. Epidermal grafting. An original technique and its application in achromic and granulating areas. Arch Dermatol 1971; 104: 592-600.
70. Suvanprakorn P, Dee-Ananlap S, Pongssomboon C et al. Melanocyte autologous grafting for treatment of leukoderma. J Am Acad Dermatol 1985; 13: 968-974.
71. Koga M. Epidermal grafting using the tops of suction blisters in the treatment of vitiligo. Arch Dermatol 1988; 124: 1656-1658.
72. Selmanowitz V J, Rabinowitz A D, Orentreich N. Pigmentary correction of pibaldism by autografts. I. Procedures and clinical findings. J Dermatol Surg Oncol 1977; 3: 615-622.
73. Falabella R. Repigmentation of leukoderma by autologous epidermal grafting J Dermatol Surg Oncol 1984; 10: 136-144.
74. Behl P N. Repigmentation of leukodenna (letter). J Dermatol Surg Oncol 1984; 10: 669-670.
75. Behl P N. Repigmentation of segmental vitiligo by autologous minigrafting (letter). J Am Acad Dermatol 1985; 12: 118-119.
76. Bonafé J L, LassereJ, Chavoin J P et al. Pigmentation induced in vitiligo by normal skin grafts and PUVA stimulation: A preliminary study. Dermatologica 1983; 166: 113-116.
77. Orentreich N, Selmanovitz V J. Autograft repigmentation of leukoderma. Arch Dermatol 1972; 105: 736-784.
78. Falabella R. Repigmentation of leukoderma by minigrafts of normally pigmented, autologous skin. J Dermatol Surg Oncol 1978; 4: 916-919.
79. Falabella R. Repigmentation of stable leukoderma by autologous minigrafting. J Dermatol Surg Oncol 1986; 12: 172-179.
80. Falabella R. Repigmentation of segmental vitiligo by autologous minigrafting. J Am Acad Dermatol 1983; 9: 514-521.
81. Falabella R, Barona M I, Escobar C et al. Surgical combination therapy for vitiligo and piebaldism. Dermatol Surg 1995; 21: 852-857.
82. Gauthier Y, Surlevel-Bazeilli J E. Autologous grafting with noncultured melanocytes: a simplified method for treatment of depigmented lesions. J Am Acad Dermatol 1992; 26: 191-194.
83. Lerner A B, Halaban R, Klaus S et al. Transplantation of human melanocytes. J Invest Dermatol 1987; 89: 219-224.
84. Lerner A B. Repopulation of pigment cells in patients with vitiligo. Arch Dermatol 1988; 124: 1701-1702.
85. Löntz W, Olsson M J, Moellmann G et al. Pigment cell transplantation for treatment of vitiligo. A progress report. J. Am Acad Dermatol 1994; 30: 591-597.
86. Plott R I, Brysk N M, Newton R C et al. A surgical treatment for vitiligo: autologous cultured-epithelial grafts. J Dermatol Surg Oncol 1989; 15: 1161-1166.
87. Falabella R, Escobar C, Borrero I. Transplantation of in vitro-cultured epidermis bearing melanocytes for repigmenting vitiligo. J Am Acad Dermatol 1989; 21: 257-264.
88. Goldstein E, Haberman H F, Menon I A et al. Non-psoralen treatment of vitiligo. Part II. Less commonly used and experimental therapies. Int J Dermatol 1992; 31: 314-319.
89. Mosher D B, Parrish J A, Fitzpatrick T B. Monobenzylether of hydroquinone. Br J Dermatol 1977; 98: 669-679.